Publication | Closed Access

Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects

ThrombosisHealthy SubjectsCardiovascular DiseasePharmacologyCardiovascular PharmacologyNonvalvular Atrial FibrillationFibrinolysisPharmacotherapyConsistent PharmacokineticsCoagulopathyPlatelet AntagonistMedicineAnticoagulantCardiology